Risk factors for pneumonia in the intubated patient

Infectious Disease Clinics of North America

Volumn 17, Issue 4, 2003, Pages 697-705

  Diaz, Olga ^a   Diaz, Emili ^b   Rello, Jordi ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DEVICE INFECTION; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; ENTEROBACTERIACEAE; EPIDEMIOLOGICAL DATA; HAEMOPHILUS; HUMAN; INCIDENCE; PATHOGENESIS; PNEUMONIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; VENTILATOR;

EID: 1042289397     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(03)00072-2     Document Type: Review

References (24)

1. Rello J., Torres A. Microbial causes of ventilator-associated pneumonia. Semin Respir Infect. 11:1996;24-31.
2. Rello J., Torres A., Ricart M., Valles J., Gonzalez J., Artigas A., et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 150:1994;1545-1549.
3. Rello J., Diaz E., Roque M., Valles J. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med. 159:1999;1742-1746.
4. Cook D.J., Walter S.D., Cook R.J., Griffith L.E., Guyatt G.H., Leasa D., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 129:1998;433-440.
5. Craven D.E., Kunches L.M., Kilinsky V., Lichtenberg D.A., Make B.J., Maccabe W.R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 133:1986;792-796.
6. Rello J., Paiva J.A., Baraibar J., Barcenilla F., Bodi M., Castander D., et al. International conference for the development of a consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest. 120:2001;955-970.
7. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 165:2002;867-903.
8. Hubmayr R.D. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia. Chicago, Illinois, May 2002. Intensive Care Med. 28:2002;1521-1536.
9. Cook D.J., Kollef M.H. Risk factors for ICU-acquired pneumonia. JAMA. 279:1998;1605-1606.
10. Kollef M.H. Ventilator-associated pneumonia: a multivariate analysis. JAMA. 270:1993;1965-1970.
11. Torres A., Serra-Batlles J., Ros E., Piera C., Puig de la Bellacasa J., Cobos A., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 116:1992;540-543.
12. Rello J., Sonora R., Jubert P., Artigas A., Rué M., Vallés J. Pneumonia in intubated patients: role of airway management. Am J Respir Crit Care Med. 154:1996;111-115.
13. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al, for the VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21.
14. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 104:1993;1230-1235.
15. Trouillet J.L., Chastre J., Vuagnat A., Joly-Guillou M.L., Combaux D., Dombret M.C., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 157:1998;531-539.
16. Rello J., Ricart M., Ausina V., Net A., Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Chest. 102:1992;1562-1565.
17. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novava A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 94:1993;281-288.
18. Rello J., Jubert P., Valles J., Artigas A., Rue M., Niederman M.S. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 23:1996;973-978.
19. Rello J., Ausina V., Ricart M., Puzo C., Quintana E., Net A., et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med. 20:1994;193-198.
20. Bonten M.J., Slaughter S., Ambergen A.W., Hayden M.K., van Voorhis J., Nathan C., et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 158:1998;1127-1132.
21. Baraibar J., Correa H., Mariscal D., Gallego M., Valles J., Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest. 112:1997;1050-1054.
22. Trouillet J.L., Vuagnat A., Combes A., Kassis N., Chastre J., Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis. 34:2002;1047-1054.
23. Pujol M., Corbella X., Pena C., Pallares R., Dorca J., Verdaguer R., et al. Clinical and epidemiological findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis. 17:1998;622-628.
24. Sirvent J.M., Torres A., El-Ebiary M., Castro P., de Batlle J., Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med. 155:1997;1729-1734.